KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Change in Receivables: 2015-2025

Historic Change in Receivables for Medpace Holdings (MEDP) over the last 10 years, with Sep 2025 value amounting to -$4.9 million.

  • Medpace Holdings' Change in Receivables fell 147.11% to -$4.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $61.8 million, marking a year-over-year increase of 181.11%. This contributed to the annual value of -$2.2 million for FY2024, which is 104.64% down from last year.
  • Medpace Holdings' Change in Receivables amounted to -$4.9 million in Q3 2025, which was down 106.08% from $79.9 million recorded in Q2 2025.
  • In the past 5 years, Medpace Holdings' Change in Receivables ranged from a high of $79.9 million in Q2 2025 and a low of -$19.1 million during Q1 2024.
  • Over the past 3 years, Medpace Holdings' median Change in Receivables value was $9.0 million (recorded in 2023), while the average stood at $11.2 million.
  • Its Change in Receivables has fluctuated over the past 5 years, first skyrocketed by 7,103.12% in 2022, then slumped by 540.06% in 2024.
  • Over the past 5 years, Medpace Holdings' Change in Receivables (Quarterly) stood at -$64,000 in 2021, then spiked by 7,103.12% to $4.5 million in 2022, then skyrocketed by 100.09% to $9.0 million in 2023, then crashed by 270.32% to -$15.3 million in 2024, then slumped by 147.11% to -$4.9 million in 2025.
  • Its Change in Receivables stands at -$4.9 million for Q3 2025, versus $79.9 million for Q2 2025 and $2.1 million for Q1 2025.